Annual return of 118.79% - See How Click here now!
Assured Guaranty Ltd. (NYSE: AGO | Quote | Chart | News | PowerRating) through its subsidiaries, provides credit enhancement products to the public finance, structured finance, and mortgage markets in the United States and internationally. Its credit enhancement products are financial guaranty or other types of financial support, including credit derivatives that improve the credit of underlying debt obligations. The company operates in four segments: Financial Guaranty Direct, Financial Guaranty Reinsurance, Mortgage Guaranty, and Other. Financial Guaranty Direct segment provides an unconditional and irrevocable guaranty that protects the holder of a financial obligation against non-payment of principal and interest when due. Financial Guaranty Reinsurance segment includes agreements whereby the company is a reinsurer and agrees to indemnify a primary insurance company against part or all of the loss. Mortgage Guaranty segment provides protection to mortgage lending institutions against the default of borrowers on mortgage loans that, at the time of the advance, had a loan-to-value in excess of a specified ratio. Other segment offers equity layer credit protection, trade credit reinsurance, title reinsurance, and auto residual value reinsurance. The company markets its products directly and through financial institutions. Assured Guaranty, Ltd. was founded in 2003 and is based in Hamilton, Bermuda. With 90.84 million shares outstanding and 21.22 million shares declared short as of July 2008, there is a failure to deliver in shares of AGO. According to quarterly data provided by the SEC, there were still 78,340 shares of AGO that were failing-to-deliver as of August 14, 2007.
General Steel Holdings Inc (NYSE: GSI | Quote | Chart | News | PowerRating) through its subsidiaries, operates a portfolio of steel companies serving various industries primarily in the People's Republic of China. It manufactures hot-rolled carbon and silicon steel sheets for use in the production of tractors, agricultural vehicles, shipping containers, and in other specialty markets; spiral-weld steel pipes to transport natural gas, oil, and stream for the energy sector; and reinforced bars and round bars for the construction industry and infrastructure. The company also provides integrated steel, crude steel, pig iron, and high-speed wires. It sells its products primarily to distributors. General Steel Holdings, Inc. was founded in 1988 and is headquartered in Beijing, the People's Republic of China. With 34.86 million shares outstanding and 1.94 million shares declared short as of July 2008, there is a failure to deliver in shares of GSI. According to quarterly data provided by the SEC, there were still 13,257 shares of GSI that were failing-to-deliver as of September 26, 2007.
NovaGold Resources Inc (AMEX: NG | Quote | Chart | News | PowerRating) through its subsidiaries, engages in the exploration and development of gold and copper properties in Alaska and British Columbia. The company owns interest in the Donlin Creek gold project in southwestern Alaska; a 50% interest in the Galore Creek copper-gold-silver project in British Columbia; and a 100% interest in the Grace claims located in northwestern British Columbia. It also owns a 100% interest in the Nome Gold property, which comprises Rock Creek, Big Hurrah, and Nome Gold projects located near the town of Nome, Alaska. In addition, NovaGold Resources has an option to acquire a 51% joint venture interest in the Ambler property with copper, zinc, gold, silver, and lead deposits located in northern Alaska. Further, the company operates hydroelectric projects located in British Columbia; and engages in the sale of sand, gravel, and land. The company was founded in 1984. It was formerly known as NovaCan Mining Resources (l985) Limited and changed its name to NovaGold Resources, Inc. in 1987. NovaGold Resources is based in Vancouver, Canada. With 105.16 million shares outstanding and 5.51 million shares declared short as of July 2008, there is a failure to deliver in shares of NG. According to quarterly data provided by the SEC, there were still 71,096 shares of NG that were failing-to-deliver as of September 28, 2007.
Titan Pharmaceuticals Inc (AMEX: TTP | Quote | Chart | News | PowerRating) together with its subsidiaries, operates as a biopharmaceutical company that develops proprietary therapeutics for the treatment of central nervous system disorders, cardiovascular disease, and bone disease. Its products include Probuphine, a Phase III clinical trial product for the treatment of opioid addiction; Iloperidone for the treatment of schizophrenia and related psychotic disorders; and Spheramine, a Phase IIb clinical trial product for the treatment of advanced Parkinson's disease. The company also holds rights to diiodothyropropionic acid, a proprietary product for the treatment of cardiovascular disease; and gallium maltolate, an oral agent for the treatment of chronic bacterial infections, bone disease, and cancer. It has collaboration with Bayer Schering Pharma AG for the development of Spheramine to treat Parkinson's disease; and with Vanda Pharmaceuticals, Inc. to develop iloperidone for the treatment of schizophrenia and related psychotic disorders. The company was founded in 1992 and is based in South San Francisco, California. With 58.28 million shares outstanding and 1.07 million shares declared short as of July 2008, there is a failure to deliver in shares of TTP. According to quarterly data provided by the SEC, there were still 41,892 shares of TTP that were failing-to-deliver as of September 14, 2007.
Lipid Sciences Inc. (NASDAQ: LIPD | Quote | Chart | News | PowerRating) a development-stage biotechnology company, engages in the research and development of products and processes to treat medical indications, such as cardiovascular diseases and viral infections in which lipids or fat components play a key role. Its technologies are based on a patented process that selectively removes lipids, such as cholesterol from targeted lipoproteins or viruses circulating in blood plasma without disrupting the nontargeted plasma proteins function. The company focuses on applications of its technologies in two areas, including cardiovascular disease using its high-density lipoproteins (HDL) therapy platform, and viral infections using its viral immunotherapy platform. The HDL therapy platform includes HDL selective delipidation, as well as HDL mimetic peptides, which consists of a sequence of amino acids that mimic the critical functional characteristics of Apolipoprotein A-I, a key protein component of HDL. This platform focuses on developing treatments for the reversal of atherosclerosis, which is the primary cause of heart attacks, strokes, and peripheral vascular disease. The viral immunotherapy platform focuses on the removal of lipid coatings from lipid-enveloped viruses and other lipid-containing infectious agents, such as human immunodeficiency virus, hepatitis B, and hepatitis C by the application of lipid sciences' delipidation technologies. It has a collaborative research and license agreement with Elanco Animal Health to research, develop, manufacture, and sell immunological products for animal health applications. The company, formerly known as NZ Corporation, was founded in 1908 and is headquartered in Pleasanton, California. With 37.13 million shares outstanding and 54,000 shares declared short as of July 2008, there is a failure to deliver in shares of LIPD. According to quarterly data provided by the SEC, there were still 19,571 shares of LIPD that were failing-to-deliver as of September 28, 2007.
Simtek Corp. (NASDAQ: SMTK | Quote | Chart | News | PowerRating) a fabless semiconductor company, designs and markets high-speed, re-programmable, and nonvolatile semiconductor memory products. It offers 16, 64, and 256-kilobit and 1-megabit nonvolatile static random access memory products, which consist of nonvolatile memories that combine static random access memory and nonvolatile elements within memory cell on a single silicon chip. The company's products are used in various systems, including RAID servers, industrial automation, GPS navigational systems, robotics, medical instrumentation, and networking and telecommunications equipment. Simtek Corporation sells its products primarily in the United States, Europe, and Asia/Pacific. The company was founded in 1986 and is headquartered in Colorado Springs, Colorado. With 16.55 million shares outstanding and 4,100 shares declared short as of July 2008, there is a failure to deliver in shares of SMTK. According to quarterly data provided by the SEC, there were still 31,533 shares of SMTK that were failing-to-deliver as of August 9, 2007.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,100,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
CONTACT: Thomas Ronk, CEO, BUYINS.NET Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
